Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review)
- 13 July 2021
- journal article
- review article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 48 (3) , 1-18
Abstract
Cell therapy is becoming an attractive alternative for the treatment of patients with no‑option critical limb ischemia (CLI). The main benefits of cell therapy are the induction of therapeutic angiogenesis and neovascularization that lead to an increase in blood flow in the ischemic limb and tissue regeneration in non‑healing cutaneous trophic lesions. In the present review, the current state of the art of strategies in the cell therapy field are summarized, focusing on intra‑operative autologous cell concentrates in diabetic patients with CLI, examining different sources of cell concentrates and their mechanisms of action. The present study underlined the detrimental effects of the diabetic condition on different sources of autologous cells used in cell therapy, and also in delaying wound healing capacity. Moreover, relevant clinical trials and critical issues arising from cell therapy trials are discussed. Finally, the new concept of cell therapy as an adjuvant therapy to increase wound healing in revascularized diabetic patients is introduced.Keywords
This publication has 100 references indexed in Scilit:
- Noninvasive management of the diabetic foot with critical limb ischemia: current options and future perspectivesTherapeutic Advances in Endocrinology and Metabolism, 2011
- Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healingBlood, 2011
- Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell inductionBlood, 2010
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- Concise Review: Bone Marrow-Derived Stem/Progenitor Cells in Cutaneous Repair and RegenerationStem Cells, 2010
- Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashionJournal of Leukocyte Biology, 2008
- Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesisJournal of Experimental Medicine, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal CellsCirculation, 2004
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001